Chao Gao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Chao Gao has a total of 50 co-authors. Here are the top co-authors by number of shared publications:
- David R. HolmesJr
Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA
3 shared publications Marie-Claude Morice
Cardiovascular European Research Center, Paris, France
2 shared publications- Michael J. Mack
Baylor Scott and White Health, Plano, TX (M.J.M.).
2 shared publications - Patrick W. Serruys
University of Galway
2 shared publications - Scot Garg
Department of Cardiology, Royal Blackburn Hospital, Blackburn, United Kingdom; School of Medicine, University of Central Lancashire, Preston, United Kingdom
2 shared publications - Yoshinobu Onuma
Department of Cardiology, University of Galway, Galway, Ireland; CORRIB Research Centre for Advanced Imaging and Core Lab, University of Galway, Galway, Ireland
2 shared publications
Latest Publications
- Top Cited PapersOpen Access
- 20 February 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (2) , e0314134
Effects of high-intensity interval training versus moderate-intensity continuous training on cardiorespiratory and exercise capacity in patients with coronary artery disease: A systematic review and meta-analysis
Background: With the increasing utilization of cardiac rehabilitation in clinical treatment and prognosis for patients with cardiovascular diseases, exercise training has become a crucial component. High-intensity interval training (HIIT) and moderate-intensity continuous training (MICT) are commonly employed in rehabilitating patients with cardiovascular diseases. However, further investigation is required to determine whether HIIT and MICT can effectively enhance the prognosis of patients with coronary artery disease. Therefore, this study aims to assess the effectiveness of HIIT and MICT interventions, optimal intervention duration for different intensity levels of training, as well as effective training modalities that improve cardiorespiratory function and exercise capacity among patients. Methods: We conducted a comprehensive search of the Cochrane Library, PubMed, EMbase, Web of Science, and CINAHL databases for randomized controlled trials (RCTs) pertaining to high-intensity interval training (HIIT) and moderate-intensity continuous training (MICT) interventions in patients with coronary artery disease from inception until publication on September 26, 2024. Two independent researchers assessed articles that met the inclusion criteria and analyzed the results using Sata 17.0 software. Forest plots were employed to evaluate the impact of HIIT and MICT on outcome indicators. Sensitivity analysis and funnel plot assessment were performed to examine publication bias. Subgroup analysis was conducted to determine optimal intervention duration and training methods. Results: A total of 22 studies with 1364 patients were included in the study, including the HIIT group (n = 685) and the MICT group (n = 679). The results showed that compared to MICT, HIIT significantly increased PeakVO2(Peak oxygen uptake)[WMD = 1.42mL /kg/min 95%CI (0.87, 1.98), P = 0.870, I2 = 0%], 6MWT(6-minute walk test)[WMD = 18.60m 95%CI (2.29, 34.92), P = 0.789, I2 = 0%], PHR(Peak heart rate)[WMD = 4.21bpm 95%CI (1.07, 7.36), P = 0.865, I2 = 0%], DBP(diastolic blood pressure)[WMD = 3.43mmHg 95%CI (1.09, 5.76), P = 0.004, I2 = 60.2%]. However, in LVEF(left- ventricular ejection fraction)[WMD = 0.32mL 95%CI (-1.83, 2.46), P = 0.699, I2 = 0%], LVEDV(left ventricular end-diastolic volume)[WMD = 0.91 ml 95%CI (-1.83, 2.46), P = 0.995, I2 = 0%] and SBP(systolic blood pressure)[WMD = 1.85mmHg 95%CI (-0.23, 3.93),P = 0.266, I2 = 18.2%], there was no significant difference between HIIT and MICT. Conclusion: Based on the findings of this systematic review, HIIT demonstrates superior efficacy compared to MICT in enhancing PeakVO2, PHR, 6MWT and DBP. However, no significant differences were observed in LVEF, LVEDV, and SBP. In summary, HIIT exhibits potential for improving cardiopulmonary function and exercise capacity among patients with coronary artery disease.
- 20 February 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (2) , e0314134
Top Cited PapersOpen AccessEffects of high-intensity interval training versus moderate-intensity continuous training on cardiorespiratory and exercise capacity in patients with coronary artery disease: A systematic review and meta-analysis
Background: With the increasing utilization of cardiac rehabilitation in clinical treatment and prognosis for patients with cardiovascular diseases, exercise training has become a crucial component. High-intensity interval training (HIIT) and moderate-intensity continuous training (MICT) are commonly employed in rehabilitating patients with cardiovascular diseases. However, further investigation is required to determine whether HIIT and MICT can effectively enhance the prognosis of patients with coronary artery disease. Therefore, this study aims to assess the effectiveness of HIIT and MICT interventions, optimal intervention duration for different intensity levels of training, as well as effective training modalities that improve cardiorespiratory function and exercise capacity among patients. Methods: We conducted a comprehensive search of the Cochrane Library, PubMed, EMbase, Web of Science, and CINAHL databases for randomized controlled trials (RCTs) pertaining to high-intensity interval training (HIIT) and moderate-intensity continuous training (MICT) interventions in patients with coronary artery disease from inception until publication on September 26, 2024. Two independent researchers assessed articles that met the inclusion criteria and analyzed the results using Sata 17.0 software. Forest plots were employed to evaluate the impact of HIIT and MICT on outcome indicators. Sensitivity analysis and funnel plot assessment were performed to examine publication bias. Subgroup analysis was conducted to determine optimal intervention duration and training methods. Results: A total of 22 studies with 1364 patients were included in the study, including the HIIT group (n = 685) and the MICT group (n = 679). The results showed that compared to MICT, HIIT significantly increased PeakVO2(Peak oxygen uptake)[WMD = 1.42mL /kg/min 95%CI (0.87, 1.98), P = 0.870, I2 = 0%], 6MWT(6-minute walk test)[WMD = 18.60m 95%CI (2.29, 34.92), P = 0.789, I2 = 0%], PHR(Peak heart rate)[WMD = 4.21bpm 95%CI (1.07, 7.36), P = 0.865, I2 = 0%], DBP(diastolic blood pressure)[WMD = 3.43mmHg 95%CI (1.09, 5.76), P = 0.004, I2 = 60.2%]. However, in LVEF(left- ventricular ejection fraction)[WMD = 0.32mL 95%CI (-1.83, 2.46), P = 0.699, I2 = 0%], LVEDV(left ventricular end-diastolic volume)[WMD = 0.91 ml 95%CI (-1.83, 2.46), P = 0.995, I2 = 0%] and SBP(systolic blood pressure)[WMD = 1.85mmHg 95%CI (-0.23, 3.93),P = 0.266, I2 = 18.2%], there was no significant difference between HIIT and MICT. Conclusion: Based on the findings of this systematic review, HIIT demonstrates superior efficacy compared to MICT in enhancing PeakVO2, PHR, 6MWT and DBP. However, no significant differences were observed in LVEF, LVEDV, and SBP. In summary, HIIT exhibits potential for improving cardiopulmonary function and exercise capacity among patients with coronary artery disease.
- Open Access
- 1 December 2023
- Published by Taylor & Francis in International Journal of Nanomedicine
- Vol. ume 18, 7441-7468
Biomembrane-Derived Nanoparticles in Alzheimer’s Disease Therapy: A Comprehensive Review of Synthetic Lipid Nanoparticles and Natural Cell-Derived Vesicles
Current therapies for Alzheimer’s disease used in the clinic predominantly focus on reducing symptoms with limited capability to control disease progression; thus, novel drugs are urgently needed. While nanoparticles (liposomes, high-density lipoprotein-based nanoparticles) constructed with synthetic biomembranes have shown great potential in AD therapy due to their excellent biocompatibility, multifunctionality and ability to penetrate the BBB, nanoparticles derived from natural biomembranes (extracellular vesicles, cell membrane-based nanoparticles) display inherent biocompatibility, stability, homing ability and ability to penetrate the BBB, which may present a safer and more effective treatment for AD. In this paper, we reviewed the synthetic and natural biomembrane-derived nanoparticles that are used in AD therapy. The challenges associated with the clinical translation of biomembrane-derived nanoparticles and future perspectives are also discussed.
- 1 December 2023
- Published by Taylor & Francis in International Journal of Nanomedicine
- Vol. ume 18, 7441-7468
Open AccessBiomembrane-Derived Nanoparticles in Alzheimer’s Disease Therapy: A Comprehensive Review of Synthetic Lipid Nanoparticles and Natural Cell-Derived Vesicles
Current therapies for Alzheimer’s disease used in the clinic predominantly focus on reducing symptoms with limited capability to control disease progression; thus, novel drugs are urgently needed. While nanoparticles (liposomes, high-density lipoprotein-based nanoparticles) constructed with synthetic biomembranes have shown great potential in AD therapy due to their excellent biocompatibility, multifunctionality and ability to penetrate the BBB, nanoparticles derived from natural biomembranes (extracellular vesicles, cell membrane-based nanoparticles) display inherent biocompatibility, stability, homing ability and ability to penetrate the BBB, which may present a safer and more effective treatment for AD. In this paper, we reviewed the synthetic and natural biomembrane-derived nanoparticles that are used in AD therapy. The challenges associated with the clinical translation of biomembrane-derived nanoparticles and future perspectives are also discussed.
- 14 November 2022
- Published by Elsevier in Engineering Fracture Mechanics
- Vol. 277, 108943
Editorial VSI Fracture behavior of additively manufactured materials and structures
- 14 November 2022
- Published by Elsevier in Engineering Fracture Mechanics
- Vol. 277, 108943
Editorial VSI Fracture behavior of additively manufactured materials and structures
- 14 October 2022
- Published by Taylor & Francis
- p. 382-388
Study on the influence of ultra-fine limestone powder composite admixture on concrete properties
Mineral admixtures have become an essential component for the configuration of high-performance concrete. This paper mainly studies the effects of different types of mineral admixtures on the working performance, mechanical properties, and durability (impermeability, carbonization resistance and shrinkage strain) of concrete. The results show that: compared with other mineral admixtures, the ultra-fine limestone powder composite admixture has a better effect of replacing part of the cement. Although it reduces the compressive strength of concrete to a certain extent, its own “micro-filling effect”, “Activity effect” and “microcrystalline nucleus effect” can significantly improve the fluidity of the fresh mix and related durability.
- 14 October 2022
- Published by Taylor & Francis
- p. 382-388
Study on the influence of ultra-fine limestone powder composite admixture on concrete properties
Mineral admixtures have become an essential component for the configuration of high-performance concrete. This paper mainly studies the effects of different types of mineral admixtures on the working performance, mechanical properties, and durability (impermeability, carbonization resistance and shrinkage strain) of concrete. The results show that: compared with other mineral admixtures, the ultra-fine limestone powder composite admixture has a better effect of replacing part of the cement. Although it reduces the compressive strength of concrete to a certain extent, its own “micro-filling effect”, “Activity effect” and “microcrystalline nucleus effect” can significantly improve the fluidity of the fresh mix and related durability.
- Open Access
- 1 January 2022
- Published by TMR Publishing Group in TMR Non-Drug Therapy
- Vol. 5 (2) , 7
Annual advances of acupuncture research in 2021
- 1 January 2022
- Published by TMR Publishing Group in TMR Non-Drug Therapy
- Vol. 5 (2) , 7
Open AccessAnnual advances of acupuncture research in 2021
- 1 January 2012
- Published by Springer Nature
- p. 415-423
Estimating Average Round-Trip Time from Bidirectional Flow Records in NetFlow
- 1 January 2012
- Published by Springer Nature
- p. 415-423
Estimating Average Round-Trip Time from Bidirectional Flow Records in NetFlow
- 29 December 2008
- Published by American Chemical Society (ACS) in Chemistry of Materials
- Vol. 21 (2) , 360-370
Scalable Functional Group Engineering of Carbon Nanotubes by Improved One-Step Nitrene Chemistry
- 29 December 2008
- Published by American Chemical Society (ACS) in Chemistry of Materials
- Vol. 21 (2) , 360-370
Scalable Functional Group Engineering of Carbon Nanotubes by Improved One-Step Nitrene Chemistry